PUNE, India, July 11, 2024 /PRNewswire/ -- Stellar Market
Research, a global Healthcare Market research firm has published a
competitive intelligence and market research report on the "RFID in
Pharmaceutical Market". The RFID in Pharmaceutical Market size was
valued at USD 4.56 Bn in 2023 and the
total RFID in Pharmaceutical revenue is expected to grow at a CAGR
of 7.5 percent from 2024 to 2030, reaching nearly USD 7.57 Bn by 2030.
The report on the RFID in Pharmaceutical Market involves a
comprehensive analysis of market structure, competition, and growth
drivers. The market size is methodically estimated using a
bottom-up approach to understand growth patterns. Key insights
typically cover major drivers at global and regional levels,
challenges for future growth, and opportunities arising from
technological advancements. Regional analyses provide information
on market leaders, penetration rates, and geographical factors
influencing the industry.
The segmentation by type, component, distribution channel, and
application aids in understanding the target audience, emerging
trends, and market composition. Primary and secondary research
techniques are combined in research studies on the RFID in
Pharmaceutical market. Both qualitative and quantitative analyses
are employed using tools like SWOT, PESTLE, and Porter's Five
Forces to guide investment and marketing decisions.
Get your Sample
PDF: https://www.stellarmr.com/report/req_sample/Global-RFID-in-Pharmaceutical-Market-/1415
Market Size in
2023
|
USD 4.56 Bn.
|
Market Size in
2030
|
USD 7.57 Bn.
|
CAGR
|
7.5 percent
(2024-2030)
|
Forecast
Period
|
2024-2030
|
Base
Year
|
2023
|
Number of
Pages
|
278
|
No. of
Tables
|
118
|
No. of Charts and
Figures
|
110
|
Segment
Covered
|
Type, Component,
Distribution Channel, and Application
|
Regional
Scope
|
North America, Europe,
Asia Pacific, Middle East and Africa, South America
|
Report
Coverage
|
Market Share, Size
& Forecast by Revenue | 2024−2030, Market Dynamics, Growth
Drivers, Restraints, Investment Opportunities, and Key Trends,
Competitive Landscape, Key Players Benchmarking, Competitive
Analysis, MMR Competition Matrix, Competitive Leadership Mapping,
Global Key Players' Market Ranking Analysis.
|
What's New: Recent Additions and Updates
- An in-depth analysis of the dynamics of the growing RFID market
in the pharmaceutical industry, taking into account concerns about
medicine expiry and overstocking.
- Analysis of the cost implications of RFID implementation,
including hardware, software, and integration costs.
- Innovations in the development of flexible and wearable RFID
tags are opening new possibilities for their application in the
pharmaceutical industry.
RFID in Pharmaceutical Market Dynamics
The World Health Organization (WHO) estimates that up to 10% of
medications in low- and middle-income countries are counterfeit,
making counterfeit pharmaceuticals a serious concern. Radio
Frequency Identification (RFID) technology helps to mitigate the
risks associated with counterfeiting, which costs the
pharmaceutical industry an estimated $200
billion in revenue losses annually and puts patients' health
at serious risk. RFID in pharmaceutical technology meets the
critical need for tracking and verifying medications through the
supply chain. The demand for RFID in pharmaceutical is increasing
as it not only ensures the authenticity of drugs but also aids in
preventing medication errors, which affect more than 1.5 million
patients in the U.S. annually. Research by SMR, states that RFID
implementation results in up to 80% less inventory shrinkage, which
translates into significant cost savings. Additionally, strict
regulations that provide detailed and accurate records of the
handling and transportation of pharmaceutical products are enforced
for the pharmaceutical industry. RFID technology makes it simple to
comply with these regulations while ensuring the integrity and
safety of these goods. Analysing the competitive landscape,
including major players helps identify market opportunities and
potential competitive advantages.
Request a Sample
Report: https://www.stellarmr.com/report/req_sample/Global-RFID-in-Pharmaceutical-Market-/1415
RFID in Pharmaceutical Market Regional Insights
The rapid rise of the pharmaceutical sector in China and
India, which rank among the
world's top manufacturers and users of pharmaceuticals are
making significant investments in cutting-edge technology to boost
the effectiveness of their supply chains and guarantee adherence to
international norms. The China RFID in pharmaceutical market has
been observing growth as the government and regulatory bodies have
taken the initiative to enact laws that improve medication safety
and traceability. China is making
significant investments in the creation of RFID-enabled IoT
infrastructure and smart logistics. It is expected that by 2025,
Chinese investments in the Internet of Things will surpass
$300 billion by increasing efficiency
lowering the danger of counterfeiting, and accelerating the
adoption of RFID in the pharmaceutical supply chain. Additionally,
the growing cost of healthcare in India is a major driver behind the use of RFID
technology in pharmaceuticals. The need for RFID in the
pharmaceutical industry is further supported by the growing
adoption of smart logistics and digital health solutions. Countries
at the forefront of RFID technology development include
South Korea and Japan, which creates an atmosphere that is
favorable to the adoption of RFID in pharmaceutical industry.
RFID in Pharmaceutical Market Segmentation
By Type
- Chipped RFID
- Chipless RFID
By Component
- RFID Tags
- RFID Readers
- RFID Middleware
By Application
- Drug Track and Trace System
- Asset Tracking
- Patient Safety
- Others
RFID in Pharmaceutical Market Key Competitors include
- Zebra Technologies Corporation
- Avery Dennison Corporation
- Impinj, Inc.
- Alien Technology, LLC
- CCL Industries Inc.
- Mojix, Inc.
- GAO RFID Group
- Others
Access a Free Sample
Report: https://www.stellarmr.com/report/req_sample/Global-RFID-in-Pharmaceutical-Market-/1415
Key questions answered in the RFID in Pharmaceutical Market
are:
- What is RFID in Pharmaceutical?
- What is the current growth rate of the RFID in Pharmaceutical
Market?
- Who are the key players in the RFID in Pharmaceutical
Market?
- What are the strategies used by competitors in the RFID in
Pharmaceutical Market?
- What are the growth prospects in developing countries for the
RFID in Pharmaceutical Market?
- Which segment is expected to witness the fastest growth and why
in the RFID in Pharmaceutical Market in 2023?
- What are the factors affecting growth in the RFID in
Pharmaceutical Market?
- Who held the largest market share in the RFID in Pharmaceutical
Market?
- What is the demand pattern for the RFID in Pharmaceutical
Market?
- What are the opportunities for the RFID in Pharmaceutical
Market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2022)
- Past Pricing and price curve by region (2018 to 2022)
- Market Size, Share, Size & Forecast by Different Segment |
2024−2030
- Market Dynamics – Growth Drivers, Restraints, Opportunities,
and Key Trends by Region
- Market Segmentation – A detailed analysis by Type, Component,
Distribution Channel, Application, and Region
- Competitive Landscape – Profiles of selected key players by
region in a strategic perspective
- Competitive landscape – Market Leaders, Market Followers,
Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER's analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Stellar Market Research a leading Healthcare research firm,
has also published the following reports:
Wi-Fi 6E Chipset Market: The market size is valued at
11.55 Billion in 2023 and is expected to reach 47.55 Billion by the
year 2030 at a 22.4% CAGR during the forecast period for
2024-2030.
Cosmetology Market: The market size was valued at
USD 118.93 Bn. in 2023 and the total
Cosmetology revenue is expected to grow at a CAGR of 10.5% from
2024 to 2030, reaching nearly USD 239.24
Bn. by 2030.
Augmented Bone Graft Market: The market size was valued
at USD 2.49 Bn. in 2023 and the total
Augmented Bone Graft Market size is expected to grow at a CAGR of
6.97 % from 2024 to 2030, reaching nearly USD 3.99 Bn. by 2030.
North America Insulin Pump Market: The market is
estimated to grow at a CAGR of 12.1% during the forecast period.
North America Insulin Pump Market is expected to reach US$ 4.28 Bn. in 2030 from US$ 1.92 Bn. in 2023.
Endoscopic Retrograde Cholangiopancreatography Market:
The market is expected to reach US$ 2.49
Bn. in 2030 from US$ 1.49 Bn.
in 2023 at a CAGR of 7.6%.
About Stellar Market Research:
Stellar Market Research is a multifaceted market research and
consulting company with professionals from several industries. Some
industries we cover include medical devices, pharmaceutical
manufacturers, science and engineering, electronic components,
industrial equipment, technology and communication, cars and
automobiles, chemical products and substances, general merchandise,
beverages, personal care, and automated systems.
Contact Stellar Market Research:
S.no.8, h.no. 4-8
Pl.7/4,
Pinnac Memories Fl. No. 3,
Pune, Maharashtra, 411029
sales@stellarmr.com
+91 9607365656
Follow us:
LinkedIn | Twitter |
Facebook | Instagram |
Logo:
https://mma.prnewswire.com/media/2458342/Stellar_Market_Research_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/rfid-in-pharmaceutical-market-to-reach-usd-7-57-bn-at-a-cagr-of-7-5-percent-by-2030--says-stellar-market-research-302194879.html